Schildkraut J J, Meyer R E, Orsulak P J, Mirin S M, Roffman M, Platz P A, Grab E, Randall M E, McDougle M
Natl Inst Drug Abuse Res Monogr Ser. 1975 Nov(3):137-45.
In a study of the effects of heroin administration in nine human subjects, urinary catecholamines and metabolites were examined during an initial drug-free baseline period, a ten-day period of heroin administration and a subsequent period of methadone detoxification. All catecholamines and metabolites tended to be increased over baseline values on the first day of heroin administration. However, markedly different patterns of change emerged on subsequent days of heroin administration. Norepinephrine and normetanephrine remained increased throughout heroin administration. Epinephrine was increased during the early phase of heroin administration but returned to baseline values during the latter phase of heroin administration. After the increase on the first day of heroin administration, metanephrine decreased and substantial decrements below baseline values occurred during the latter phase of heroin administration. After increasing on the first day of heroin administration, 3-methoxy-4-hydroxy-mandelic acid (VMA) returned to approximately baseline values. During heroin administration, an increase in 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion was observed in a subgroup of four of the nine subjects studied. This is in contrast to the increase in normetanephrine excretion and the decrease in metanephrine excretion that was observed in the entire group of nine subjects. It is conceivable that persistance of, or development of, tolerance might account for the failure to observe an increase in MHPG excretion in all of the subjects. It appeared as if the increase in MHPG excretion began on the day prior to the administration of heroin in the subgroup of patients with increased MHPG excretion during heroin administration, suggesting the possibility of an anticipatory or conditioned response, with the anticipation of heroin producing an increase in MHPG excretion.
在一项针对9名人类受试者进行海洛因给药效果的研究中,对他们在最初无药物的基线期、为期十天的海洛因给药期以及随后的美沙酮脱毒期的尿儿茶酚胺和代谢产物进行了检测。在海洛因给药的第一天,所有儿茶酚胺和代谢产物往往都比基线值有所增加。然而,在海洛因给药的后续几天出现了明显不同的变化模式。在整个海洛因给药期间,去甲肾上腺素和去甲变肾上腺素一直保持增加。肾上腺素在海洛因给药的早期阶段增加,但在海洛因给药的后期阶段恢复到基线值。在海洛因给药的第一天增加后,变肾上腺素减少,并且在海洛因给药的后期阶段出现了大幅低于基线值的下降。在海洛因给药的第一天增加后,3-甲氧基-4-羟基扁桃酸(VMA)恢复到大约基线值。在海洛因给药期间,在所研究的9名受试者中的4名受试者组成的一个亚组中观察到3-甲氧基-4-羟基苯乙二醇(MHPG)排泄增加。这与在整个9名受试者组中观察到的去甲变肾上腺素排泄增加和变肾上腺素排泄减少形成对比。可以想象,耐受性的持续存在或发展可能是导致并非所有受试者都观察到MHPG排泄增加的原因。在海洛因给药期间MHPG排泄增加的患者亚组中,似乎MHPG排泄增加始于海洛因给药前一天,这表明存在预期或条件反应的可能性,即对海洛因的预期会导致MHPG排泄增加。